Manulife closes C$3.20 billion deal as Manulife Financial stock trades at EUR 37.10

Published on 10/08/2026 at 16:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Manulife closed a C$3.20 billion reinsurance deal on October 1, 2026. Manulife Financial stock costs EUR 37.10 after EUR 37.22.

Key points in brief

Manulife closed a C$3.20 billion long-term-care reinsurance transaction on October 1, 2026.
The deal transfers biometric risk at an 80 percent quota share and reduces long-term-care morbidity sensitivity by 24 percent.
Manulife stock was EUR 37.10 at Lang & Schwarz on October 8, 2026, down 0.32 percent versus EUR 37.22.
Second-quarter core earnings per share grew 16 percent year over year, while APE sales rose 21 percent.

MFC, CA56501R1064, Illustration mit AI erstellt.

Manulife Financial Corporation (CA56501R1064) was trading at EUR 37.10 at Lang & Schwarz on October 8, 2026 at 4:12 p.m. CEST, down 0.32 percent versus the prior close of EUR 37.22. The company had closed a C$3.20 billion long-term-care reinsurance transaction on October 1, 2026, transferring biometric risk to Munich Re Life US, according to Newswire.

Three events reshape risk

On August 6, 2026, Manulife reported second-quarter results with APE sales up 21 percent year over year and core earnings per share up 16 percent, according to Yahoo Finance. On September 11, 2026, the company established US$750 million of subordinated notes carrying a 6.146 percent fixed rate until 2036, according to StockTitan. On October 1, Manulife closed the reinsurance deal with reserves of C$3.20 billion at an 80 percent quota share, according to Newswire.

What does the deal change?

The transaction reduces Manulife's cumulative long-term-care morbidity sensitivity by 24 percent, while its first-year core-earnings impact is expected to be C$30 million, according to Newswire. The company retains administration and asset management, so the structure transfers biometric risk without the asset disposal effects associated with earlier transactions.

The second-quarter figures provide the operating counterweight. Core earnings per share rose 16 percent year over year, APE sales increased 21 percent, and core return on equity reached 16.30 percent, up 130 basis points from the prior-year quarter, according to Yahoo Finance. Those figures frame the transaction as a risk-management move alongside continued earnings growth, rather than as a standalone earnings event.

Next results date is November 4

Manulife's next earnings date is November 4, 2026, according to Yahoo Finance. The date gives investors the next scheduled test of whether the 16 percent core earnings-per-share growth and the company's risk reduction can continue together.

Stock trades at EUR 37.10

Manulife Financial stock was trading at EUR 37.10 at Lang & Schwarz on October 8, 2026 at 4:12 p.m. CEST, down 0.32 percent versus the EUR 37.22 prior close. On the NYSE, the finance data quote was USD 41.41 at 2:26 p.m. UTC on October 8, 2026, with a market capitalization of USD 69.1 billion and a 52-week range of USD 31.41 to USD 45.33. The company trades as MFC on the New York and Toronto stock exchanges, according to Newswire. The further course of trading is shown by the continuously updated real-time quote of Manulife Financial stock.